Cellecta Limited Company accounts
Cellecta Limited Company accounts
COMPANY REGISTRATION NUMBER:
04215957
|
|
|
|
FINANCIAL STATEMENTS |
Year ended 31 December 2019
CONTENTS |
PAGE |
Officers and professional advisers |
1 |
Strategic report |
2 |
Director's report |
4 |
Independent auditor's report to the members |
6 |
Profit and loss account |
10 |
Balance sheet |
11 |
Statement of cash flows |
12 |
Notes to the financial statements |
13 |
|
OFFICERS AND PROFESSIONAL ADVISERS |
Director |
|
Registered office |
|
|
|
|
|
|
|
England |
|
|
|
Auditor |
|
Chartered Accountants & statutory auditor |
|
Cedar House |
|
Hazell Drive |
|
Newport |
|
NP10 8FY |
|
|
STRATEGIC REPORT |
Year ended 31 December 2019
Cellecta Limited is one of the UK's leading manufacturers of acoustic treatments, specialist thermal insulation products and underfloor heating components. The company operates from three sites. Manufacturing, distribution and accounts are located at a head office in Rochester, Kent, sales processing and technical support from a site in Newport, South Wales and marketing and R&D are coordinated from a facility in Poole, Dorset. The company offers its extensive range of high quality products via a nationwide network of specialist distributers and builders merchants. Strict management of costs, continual focus of production efficiencies and unrivalled customer services are the primary reasons for the company's prolonged success. To maintain margin expectations, the vast majority of the company's products are supported by third party accreditation, which in turn is reinforced by the company utilising ISO 9001 as a management improvement tool. The year saw outstanding financial performance with sales of £21,551,894, which yielded a gross profit of £(11,926,511) at a margin of 44.7% (2018 - 43.9%). The financial performance was a result of a number of factors including: - Strict controls of purchasing, manufacturing processes and flexibility in pricing - Strong focus on specification of high end value products by the sales team - Continual targeted marketing campaigns. The company monitors performance on a regular basis with key performance indications such as: - Monthly sales compared to budget - Customer monthly sales performance compared to budget and previous periods - Transportation costs and consignment consolidation effectiveness. The company has continued to streamline production practices. In addition, investments in new production equipment has helped with diversification of product mix, increasing market penetration. Principal risks and uncertainties The business has continued to grow despite challenging market conditions. Sterling remained weak throughout 2019. Uncertainties about the actual date of Brexit and possible effects were a drain of everyone's energy and focus. Most of Cellecta's raw materials come from European Union countries, in particular Belgium, Italy and Germany. Investments in stock to mitigate against a hard Brexit were put in place three times to minimise the risks posed by delays at the port/Eurotunnel. This action made stock management difficult and disrupted the normal smooth operational flow of goods from our suppliers. The company outperformed its budget despite the political wrangling that threatened to derail the economy. Outlook First quarter trading numbers of 2020 were in line with the Board's expectations until the very end of March when the COVID-19 pandemic hit. The resulting national lockdown had a dramatically effect of trading numbers. Quarter 2 results were some 60% below expectations. Over two thirds of the staff were put on furlough. A core team of staff remained at work throughout the lockdown to ensure vital sites were kept supplied. Quarter 3 saw most of the manufacturing staff, accounts and internal sales returning to work. External staff returned on a part time basis, with wages topped up to 80% with the furlough scheme. Sales numbers increased. However, turnover is expected to come in some 20% lower than 2020's budget. As a result, the company has implemented a comprehensive business review to determine if its staff numbers are in line with foreseeable demands going into Q4 and 2021. The company has a strong balance sheet and is well positioned to cope with the downturn. The company has continued to be profitable throughout this period. Going forward the company's strict financial controls, strong brand presence and its ability to adapt to quickly to market pressures will enable it to weather the challenging financial conditions going forward. No imminent improvement in sterling's value is expected soon. Further devaluation is more than likely should the UK leave the EU at the end of the transition period without a comprehensive free trade deal. The poor value of sterling continues to impact negatively on of raw material costs. Should sterling not strengthen, profits are likely to affected negatively. To combat this, the board will continue to keep a tight rein on expenditure. Planned manufacturing investment will further improve productivity. The close relation with the company has built up over the last 19 years with its continental supply partners will be critical over the coming months. Their full involvement in the process and understanding of the new processes will ensure the transfer of Cellecta into a to third county status customer passes as painlessly as possible. The introduction of additional automated machinery has improved productivity further, with manufacturing quality and yield consistency improving. Further investments are expected to be made over the coming years to ensure the company continues to be at the forefront of innovation and remain flexible in an ever-changing market.
This report was approved by the board of directors on 28 October 2020 and signed on behalf of the board by:
|
|
Director |
|
|
DIRECTOR'S REPORT |
Year ended 31 December 2019
The director presents his report and the financial statements of the company for the year ended
31 December 2019
.
Director
The director who served the company during the year was as follows:
|
|
Dividends
Particulars of recommended dividends are detailed in note 13 to the financial statements.
Financial instruments
The company's principal financial instruments comprise, bank accounts trade debtors and trade creditors and loans. The purpose of these instruments is to raise funds and finance the company's operations. Due to the nature of the financial instruments used by the company there is no exposure to price risk. The company's approach to managing other risks applicable to the financial instruments is shown below.
In respect of bank balances the liquidity risk is managed by ensuring debtors are collected in accordance with their terms.
Trade debtors are managed in respect of credit and cash flow risk by internal policies concerning the credit offered to customers and regular monitoring of amounts outstanding.
Trade creditors liquidity risk is managed by ensuring sufficient funds are available to meet obligations as they fall due.
Events after the end of the reporting period
Subsequent to the period end, economies and financial markets around the world experienced financial falls arising from uncertainties linked to the COVID-19 pandemic. There is currently no material impact on the company and this is a non-adjusting event. The future impact of the pandemic on the company will be quantified as the situation evolves.
Disclosure of information in the strategic report
Director's responsibilities statement
Each of the persons who is a director at the date of approval of this report confirms that:
-
so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.
This report was approved by the board of directors on
28 October 2020
and signed on behalf of the board by:
|
|
Director |
|
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF
|
Year ended 31 December 2019
Opinion
Basis for opinion
Conclusions relating to going concern
We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:
-
the director's use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or
-
the director has not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the company's ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.
Other information
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the strategic report and the director's report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
the strategic report and the director's report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
Auditor's responsibilities for the audit of the financial statements
This report is made solely to the company's members, as a body, in accordance with chapter 3 of part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
|
(Senior Statutory Auditor) |
For and on behalf of |
|
Chartered Accountants & statutory auditor |
Cedar House |
Hazell Drive |
Newport |
NP10 8FY |
|
PROFIT AND LOSS ACCOUNT |
Year ended 31 December 2019
2019 |
2018 |
||
Note |
£ |
£ |
|
TURNOVER |
5 |
|
|
Cost of sales |
(
|
(
|
------------- |
------------- |
|
GROSS PROFIT |
|
|
Administrative expenses |
(
|
(
|
|
Other operating income |
6 |
|
|
------------ |
------------ |
||
OPERATING PROFIT |
7 |
|
|
Other interest receivable and similar income |
11 |
|
|
------------ |
------------ |
||
PROFIT BEFORE TAXATION |
|
|
|
Tax on profit |
12 |
(
|
(
|
------------ |
------------ |
||
PROFIT FOR THE FINANCIAL YEAR AND TOTAL COMPREHENSIVE INCOME |
|
|
|
------------ |
------------ |
||
Dividends paid and payable |
13 |
(
|
(
|
RETAINED EARNINGS AT THE START OF THE YEAR |
|
|
------------- |
------------ |
|
RETAINED EARNINGS AT THE END OF THE YEAR |
|
|
------------- |
------------ |
|
All the activities of the company are from continuing operations.
|
BALANCE SHEET |
2019 |
2018 |
|
Note |
£ |
£ |
FIXED ASSETS
Intangible assets |
14 |
|
– |
Tangible assets |
15 |
|
|
--------- |
--------- |
||
|
|
||
CURRENT ASSETS
Stocks |
16 |
|
|
Debtors |
17 |
|
|
Cash at bank and in hand |
|
|
|
------------- |
------------- |
||
|
|
||
CREDITORS: amounts falling due within one year |
18 |
(
|
(
|
------------- |
------------- |
||
NET CURRENT ASSETS |
|
|
|
------------- |
------------ |
||
TOTAL ASSETS LESS CURRENT LIABILITIES |
|
|
|
PROVISIONS |
19 |
(
|
(
|
------------- |
------------ |
||
NET ASSETS |
|
|
|
------------- |
------------ |
||
CAPITAL AND RESERVES
Called up share capital |
22 |
|
|
Capital redemption reserve |
23 |
|
|
Profit and loss account |
23 |
|
|
------------- |
------------ |
||
SHAREHOLDERS FUNDS |
|
|
|
------------- |
------------ |
||
These financial statements were approved by the
board of directors
and authorised for issue on
28 October 2020
, and are signed on behalf of the board by:
|
|
Director |
|
Company registration number:
04215957
|
STATEMENT OF CASH FLOWS |
Year ended 31 December 2019
2019 |
2018 |
|
£ |
£ |
|
CASH FLOWS FROM OPERATING ACTIVITIES
Profit for the financial year |
|
|
Adjustments for: |
||
Depreciation of tangible assets |
|
|
Amortisation of intangible assets |
|
– |
Other interest receivable and similar income |
(
|
(
|
Loss on disposal of tangible assets |
|
– |
Tax on profit |
|
|
Accrued expenses |
|
|
Changes in: |
||
Stocks |
(
|
(
|
Trade and other debtors |
(
|
(
|
Trade and other creditors |
|
(
|
------------ |
------------ |
|
Cash generated from operations |
|
|
Interest received |
|
|
Tax paid |
(
|
(
|
------------ |
------------ |
|
Net cash from operating activities |
|
|
------------ |
------------ |
|
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of tangible assets |
(
|
(
|
Purchase of intangible assets |
(
|
– |
------------ |
------------ |
|
Net cash used in investing activities |
(
|
(
|
------------ |
------------ |
|
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends paid |
(
|
(
|
------------ |
------------ |
|
Net cash used in financing activities |
(
|
(
|
------------ |
------------ |
|
NET INCREASE IN CASH AND CASH EQUIVALENTS |
|
|
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR |
6,114,897 |
5,170,119 |
------------ |
------------ |
|
CASH AND CASH EQUIVALENTS AT END OF YEAR |
|
|
------------ |
------------ |
|
|
NOTES TO THE FINANCIAL STATEMENTS |
Year ended 31 December 2019
1.
GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Innovation House, Norman Close, Rochester, Kent, ME2 2NF, England.
2.
STATEMENT OF COMPLIANCE
3.
ACCOUNTING POLICIES
Basis of preparation
Turnover
Taxation
Operating leases
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Patents, trademarks and licences |
- |
3 years straight line |
|
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Research and development
Tangible assets
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Freehold property |
- |
|
|
Plant and machinery |
- |
|
|
Fixtures, fittings and equipment |
- |
|
|
Motor vehicles |
- |
|
|
Property improvements |
- |
25
% reducing balance |
|
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Provisions
Financial instruments
Defined contribution plans
4.
JUDGEMENTS IN APPLYING ACCOUNTING POLICIES AND KEY SOURCES OF
ESTIMATION UNCERTAINTY
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Key sources of estimation uncertainty
Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome.
There are no material accounting estimates used in the preparation of these financial statements.
5.
TURNOVER
Turnover arises from:
2019 |
2018 |
|
£ |
£ |
|
Sale of goods |
|
|
------------- |
------------- |
|
The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
6.
OTHER OPERATING INCOME
2019 |
2018 |
|
£ |
£ |
|
Commission receivable |
|
|
-------- |
-------- |
|
7.
OPERATING PROFIT
Operating profit or loss is stated after charging/crediting:
2019 |
2018 |
|
£ |
£ |
|
Amortisation of intangible assets |
|
– |
Depreciation of tangible assets |
|
|
Loss on disposal of tangible assets |
|
– |
Impairment of trade debtors |
(567) |
3,403 |
Research and development expenditure written off |
|
|
--------- |
-------- |
|
8.
AUDITOR'S REMUNERATION
2019 |
2018 |
|
£ |
£ |
|
Fees payable for the audit of the financial statements |
|
|
-------- |
------- |
|
9.
STAFF COSTS
The average number of persons employed by the company during the year, including the director, amounted to:
2019 |
2018 |
|
No. |
No. |
|
Directors |
1 |
1 |
Other staff |
45 |
46 |
---- |
---- |
|
|
|
|
---- |
---- |
|
The aggregate payroll costs incurred during the year, relating to the above, were:
2019 |
2018 |
|
£ |
£ |
|
Wages and salaries |
|
|
Social security costs |
|
|
Other pension costs |
|
|
------------ |
------------ |
|
|
|
|
------------ |
------------ |
|
10.
DIRECTOR'S REMUNERATION
The director's aggregate remuneration in respect of qualifying services was:
2019 |
2018 |
|
£ |
£ |
|
Remuneration |
|
|
Company contributions to defined contribution pension plans |
|
|
--------- |
--------- |
|
|
|
|
--------- |
--------- |
|
The number of directors who accrued benefits under company pension plans was as follows:
2019 |
2018 |
|
No. |
No. |
|
Defined contribution plans |
|
|
---- |
---- |
|
11.
OTHER INTEREST RECEIVABLE AND SIMILAR INCOME
2019 |
2018 |
|
£ |
£ |
|
Interest on cash and cash equivalents |
|
|
Other interest receivable and similar income |
|
– |
-------- |
-------- |
|
|
|
|
-------- |
-------- |
|
12.
TAX ON PROFIT
Major components of tax expense
2019 |
2018 |
|
£ |
£ |
|
Current tax:
UK current tax expense |
|
|
Adjustments in respect of prior periods |
(
|
– |
------------ |
------------ |
|
Total current tax |
|
|
------------ |
------------ |
|
Deferred tax:
Origination and reversal of timing differences |
|
(
|
--------- |
------------ |
|
Tax on profit |
|
|
--------- |
------------ |
|
Reconciliation of tax expense
The tax assessed on the profit on ordinary activities for the year is lower than (2018: lower than) the
standard rate of corporation tax in the UK
of
19
% (2018:
19
%).
2019 |
2018 |
|
£ |
£ |
|
Profit on ordinary activities before taxation |
|
|
------------ |
------------ |
|
Profit on ordinary activities by rate of tax |
|
|
Adjustment to tax charge in respect of prior periods |
(302,583) |
– |
Effect of expenses not deductible for tax purposes |
|
|
Effect of capital allowances and depreciation |
|
(
|
Patent Box relief |
(23,166) |
– |
------------ |
------------ |
|
Tax on profit |
|
|
------------ |
------------ |
|
13.
DIVIDENDS
2019 |
2018 |
|
£ |
£ |
|
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year ) |
|
|
------------ |
------------ |
|
14.
INTANGIBLE ASSETS
Patents, trademarks and licences |
|
£ |
|
Cost |
|
At 1 January 2019 |
|
Additions |
|
-------- |
|
At 31 December 2019 |
|
-------- |
|
Amortisation |
|
At 1 January 2019 |
|
Charge for the year |
|
-------- |
|
At 31 December 2019 |
|
-------- |
|
Carrying amount |
|
At 31 December 2019 |
|
-------- |
|
At 31 December 2018 |
– |
-------- |
|
15.
TANGIBLE ASSETS
Freehold property |
Plant and machinery |
Fixtures, fittings and equipment |
Motor vehicles |
Property Improvements |
Total |
|
£ |
£ |
£ |
£ |
£ |
£ |
|
Cost |
||||||
At 1 Jan 2019 |
|
|
|
|
9,357 |
|
Additions |
– |
|
|
– |
– |
|
Disposals |
– |
(
|
(
|
– |
– |
(
|
--------- |
--------- |
--------- |
-------- |
------- |
------------ |
|
At 31 Dec 2019 |
|
|
|
|
9,357 |
|
--------- |
--------- |
--------- |
-------- |
------- |
------------ |
|
Depreciation |
||||||
At 1 Jan 2019 |
|
|
|
|
4,093 |
|
Charge for the year |
|
|
|
|
1,316 |
|
Disposals |
– |
(
|
(
|
– |
– |
(
|
--------- |
--------- |
--------- |
-------- |
------- |
------------ |
|
At 31 Dec 2019 |
|
|
|
|
5,409 |
|
--------- |
--------- |
--------- |
-------- |
------- |
------------ |
|
Carrying amount |
||||||
At 31 Dec 2019 |
|
|
|
|
3,948 |
|
--------- |
--------- |
--------- |
-------- |
------- |
------------ |
|
At 31 Dec 2018 |
|
|
|
|
5,264 |
|
--------- |
--------- |
--------- |
-------- |
------- |
------------ |
|
16.
STOCKS
2019 |
2018 |
|
£ |
£ |
|
Stock |
|
|
--------- |
--------- |
|
17.
DEBTORS
2019 |
2018 |
|
£ |
£ |
|
Trade debtors |
|
|
Prepayments and accrued income |
|
|
Corporation tax repayable |
|
– |
Other debtors |
|
|
------------ |
------------ |
|
|
|
|
------------ |
------------ |
|
18.
CREDITORS:
amounts falling due within one year
2019 |
2018 |
|
£ |
£ |
|
Trade creditors |
|
|
Accruals and deferred income |
|
|
Corporation tax |
– |
|
Social security and other taxes |
|
|
Director loan accounts |
|
– |
Other creditors |
|
|
------------ |
------------ |
|
|
|
|
------------ |
------------ |
|
19.
PROVISIONS
Deferred tax (note 20) |
|
£ |
|
At 1 January 2019 |
|
Charge against provision |
|
-------- |
|
At 31 December 2019 |
|
-------- |
|
20.
DEFERRED TAX
The deferred tax included in the balance sheet is as follows:
2019 |
2018 |
|
£ |
£ |
|
Included in provisions (note 19) |
|
|
-------- |
-------- |
|
The deferred tax account consists of the tax effect of timing differences in respect of:
2019 |
2018 |
|
£ |
£ |
|
Accelerated capital allowances |
|
|
Patent Box |
(83) |
(112) |
-------- |
-------- |
|
55,584 |
15,498 |
|
-------- |
-------- |
|
21.
EMPLOYEE BENEFITS
Defined contribution plans
The amount recognised in profit or loss as an expense in relation to defined contribution plans was £
123,528
(2018: £
117,128
).
22.
CALLED UP SHARE CAPITAL
Issued, called up and fully paid
2019 |
2018 |
|||
No. |
£ |
No. |
£ |
|
|
|
58 |
|
58 |
------- |
---- |
------- |
---- |
|
23.
RESERVES
The Capital Redemption Reserve represents a transfer made to reserves following the part purchase of the company's own shares.
24.
ANALYSIS OF CHANGES IN NET DEBT
At 1 Jan 2019 |
Cash flows |
At 31 Dec 2019 |
|
£ |
£ |
£ |
|
Cash at bank and in hand |
|
543,078 |
|
Debt due within one year |
– |
(1,676) |
(1,676) |
------------ |
--------- |
------------ |
|
|
|
|
|
------------ |
--------- |
------------ |
|
25.
OPERATING LEASES
The total future minimum lease payments under non-cancellable operating leases are as follows:
2019 |
2018 |
|
£ |
£ |
|
Not later than 1 year |
|
|
Later than 1 year and not later than 5 years |
|
|
-------- |
-------- |
|
|
|
|
-------- |
-------- |
|
26.
RELATED PARTY TRANSACTIONS
Included within other debtors is £1,333,062 (2018 - £1,333,062) due from a company related by common control. Goods and services totalling £323,667 (2018 - £322,398) was purchased from this entity. Included within other creditors is £1,676 (2018 - £–) due to a director. The loan is interest free and repayable on demand.
27.
CONTROLLING PARTY
The controlling party is A W Fry.